What Is Quality by Design in Pharmaceutical Development?UntitledBuilt on the ICH Quality Guidelines
The Quality by Design Training in Argentina is a one-day, instructor-led programme that teaches the Quality by Design (QbD) approach to pharmaceutical and biopharmaceutical product and process development. QbD is a systematic, science-based method that builds quality into a medicine from the design stage rather than testing it in at the end, and it is mandated by the ICH Q8(R2), Q9, Q10 and Q11 guidelines and increasingly expected by regulators including ANMAT, the US FDA and the EMA. You learn to apply the full QbD toolkit, from the Quality Target Product Profile (QTPP) and Critical Quality Attributes (CQAs) through risk assessment, Design of Experiments (DoE), the design space and the control strategy. The course suits formulation scientists, analytical chemists, process development engineers, quality assurance teams and regulatory affairs professionals across the country's laboratories and CDMOs. As Argentina strengthens its lead in Latin American biosimilars and ANMAT modernises its comparability and lifecycle rules, employers value practitioners who can design quality in and defend it in a regulatory submission. Start building that capability with Invensis Learning.










